Eli Lilly and Company (LLY)
NYSE · Healthcare
Eli Lilly and Company Total Liabilities 2007–2025
Eli Lilly and Company annual/quarterly total liabilities history from 2008 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Eli Lilly and Company total liabilities for the quarter ending December 31, 2025 were 85.94B, a 33.36% increase year-over-year.
- Eli Lilly and Company total liabilities for 2025 were 85.94B, a 33.36% increase from 2024.
- Eli Lilly and Company total liabilities for 2024 were 64.44B, a 21.06% increase from 2023.
- Eli Lilly and Company total liabilities for 2023 were 53.23B, a 37.06% increase from 2022.
- Eli Lilly and Company total liabilities for 2022 were 38.84B.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Eli Lilly and Company Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $85,941 |
| 2024 | $64,443 |
| 2023 | $53,234 |
| 2022 | $38,840 |
| 2021 | $39,827 |
| 2020 | $40,992 |
| 2019 | $36,679 |
| 2018 | $34,080 |
| 2017 | $33,389 |
| 2016 | $24,798 |
| 2015 | $20,998 |
| 2014 | $20,934 |
| 2013 | $17,617 |
| 2012 | $19,634 |
| 2011 | $20,118 |
| Eli Lilly and Company Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $85,941 |
| 2024-12-31 | $64,443 |
| 2023-12-31 | $53,234 |
| 2022-12-31 | $38,840 |
| 2021-12-31 | $39,827 |
| 2020-12-31 | $40,992 |
| 2019-12-31 | $36,679 |
| 2018-12-31 | $34,080 |
| 2017-12-31 | $33,389 |
| 2016-12-31 | $24,798 |
| 2015-12-31 | $20,998 |
| 2014-12-31 | $20,934 |
| 2013-12-31 | $17,617 |
| 2012-12-31 | $19,634 |
| 2011-12-31 | $20,118 |
| 2010-12-31 | $18,581 |
| 2009-12-31 | $17,936 |
| 2008-12-31 | $22,475 |
Eli Lilly and Company Total Liabilities — FAQ
Eli Lilly and Company (LLY) total liabilities over the last 19 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LLY's total liabilities history?
The chart and table above show Eli Lilly and Company's total liabilities by year and by quarter, including the growth rate.